The invention relates to an antibiotic substance of microbial origin, arbitrarily denominated 107891 which is produced by fermentation of Microbispra sp. ATCC PTA-5024, the pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having inhibitory activity versus susceptible microbes.

Antibiotics 107891, its factor A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof

MARINELLI, FLAVIA;
2006-01-01

Abstract

The invention relates to an antibiotic substance of microbial origin, arbitrarily denominated 107891 which is produced by fermentation of Microbispra sp. ATCC PTA-5024, the pharmaceutically acceptable salts and compositions thereof, and their use as an antibacterial agent having inhibitory activity versus susceptible microbes.
2006
Internazionale
VICURON PHARMACEUTICALS INC.
EP1646646 (A1), EP1646646 (B1)
(priority date: 2003-07-18) Also published as WO 2005014628 (A1) 2005-02-17 (priority data 2003-07-18), US2005233952(A1); 2005-10-20 (priority date: 2003-07-18), 2005203005 A1); 2005-09-15 (priority date: 2003-07-18), WO2006075988(A1); 2006-07-20 (priority date: 2005-01-19)
Lazzarini, A.; Gastaldo, L.; Candiani, P.; Ciciliato, I.; Losi, D.; Marinelli, Flavia; Selva, E.; Parenti, F.
Brevetto::Brevetto
info:eu-repo/semantics/patent
8
285
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1683133
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact